Nobel Award Honors Pioneering Immune System Discoveries

This year's Nobel Prize in Physiology or Medicine was granted for transformative discoveries that clarify how the body's defense network attacks harmful pathogens while sparing the healthy tissues.

A trio of renowned researchers—from Japan Prof. Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—received this accolade.

Their work uncovered specialized "sentinels" within the defense system that eliminate malfunctioning immune cells that could harming the body.

These findings are now paving the way for new treatments for autoimmune diseases and cancer.

The winners will divide a prize fund valued at 11m Swedish kronor.

Decisive Discoveries

"Their research has been essential for comprehending how the immune system functions and why we do not all develop serious self-attack conditions," stated the head of the Nobel Committee.

The team's research explain a core question: How does the immune system protect us from numerous invaders while leaving our own tissues intact?

Our body's protection system uses immune cells that search for indicators of disease, even pathogens and germs it has never encountered.

Such defenders employ detectors—known as recognition units—that are generated by chance in a vast number of combinations.

That provides the immune system the ability to combat a wide array of invaders, but the randomness of the mechanism unavoidably produces immune cells that may target the host.

Protectors of the Immune System

Researchers previously understood that a portion of these problematic white blood cells were destroyed in the thymus—where immune cells mature.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—known as the body's "peacekeepers"—which patrol the body to neutralize other immune cells that attack the healthy cells.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee stated, "The discoveries have laid the foundation for a novel area of investigation and accelerated the development of new treatments, for example for cancer and immune disorders."

In malignancies, regulatory T-cells block the system from attacking the tumor, so studies are aimed at reducing their numbers.

For self-attack disorders, experiments are testing increasing T-reg cells so the organism is not being harmed. A comparable approach could also be effective in reducing the risks of organ transplant failure.

Innovative Studies

Prof Shimon Sakaguchi, from a Japanese institution, performed experiments on mice that had their immune gland removed, causing autoimmune disease.

He showed that introducing defense cells from healthy mice could stop the disease—suggesting there was a system for preventing immune cells from attacking the body.

Mary Brunkow, from the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in rodents and people that led to the discovery of a gene critical for how regulatory T-cells operate.

"The pioneering work has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from accidentally attacking the healthy cells," commented a leading biological science expert.

"This research is a remarkable illustration of how basic physiological research can have broad implications for public health."